Category archive page for Myeloma.| Rare Cancer News
The oral liquid can treat specific forms of acute lymphoblastic leukemia and chronic myeloid leukemia, and other cancers, including rare ones.| Rare Cancer News
Steve Bryson is a science writer for Myeloma Research News with a PhD in biochemistry. He covers the latest news and information on a variety of myeloma topics.| Rare Cancer News
Ovarian cancer tumors' microenvironment was seen to actively suppress the anti-cancer work of immune T-cells by blocking their energy supply.| Rare Cancer News
About 15% relapsed in the first year and patients lived a median of 7.5 years, and without disease progression for a median of three years.| Rare Cancer News
The FDA granted regenerative medicine advanced therapy status to the CAR T-cell therapy P-BCMA-ALLO1 for hard-to-treat multiple myeloma.| Rare Cancer News